Diabetes Drug Faces Ban
Saturday 10th July 2010
A drug used to treat type 2 diabetes could be banned following concern that it could increase the risk of heart disease in patients. Experts fear that the diabetes drug, Avandia, which has been prescribed to thousands of Britons could raise the risk of heart disease by up to 60%.
The drug is currently being investigated by the American Food and Drug Administration after several American patients have filed legal cases against manufacturer GSK. The drug could be banned in Britain despite the drug's manufacturer, GSK claiming that the pill is safe for use.
Canadian researchers claim that the drug puts patients at a 29% greater risk of dying than other diabetes medication and increases a patient's heart-attack risk by more than 40%.
« Latest UK Health & Medical News Diabetes News »
- Types of Insulin
- Injecting Insulin
- Side Effects of Insulin
- Measuring Blood Glucose
- Glycosylated Hemoglobin
- Risk of Type 1 Diabetes
- Effects of Type 1 Diabetes
- Macrovascular Complications
- Treating Macrovascular Complications
- Microvascular Complications
- Diabetic Neuropathy
- Treating Diabetic Neuropathy
- Diabetic Retinopathy
- Diabetic Nephropathy
- Diabetic Foot
- Treating Diabetic Foot
- Problems with Diabetes
- Transplantations for Type 1 Diabetes
- Preventing Type 1 Diabetes
- Living with Type 1 Diabetes
- Living with Type Two Diabetes
- Medication for Type Two Diabetes
- Long Term Effects of Type Two Diabetes
- Diabetes A-Z
- Diabetes FAQ's
DIABETES
- Find Diabetes Clinics
- Diabetes Guide
- Diabetes in the UK
- Do you think you have Diabetes?
- Life with Diabetes
- Monitoring Diabetes
- Types of Diabetes
- Type 1 Diabetes
- Causes of Type 1 Diabetes
- Symptoms of Type 1 Diabetes
- Testing for Type 1 Diabetes
- Diet & Type 1 Diabetes
- Exercise for Diabetics
- Treatment for Type 1 Diabetes
- Type 2 Diabetes
- Causes of Type Two Diabetes
- Risk of Type Two Diabetes
- Symptoms of Type Two Diabetes
- Complications with Type Two Diabetes
- Testing for Type Two Diabetes
- Treating Type Two Diabetes